|
|
Volumn 66, Issue 1, 1997, Pages 7-10
|
|
Case against axillary lymphadenectomy for most patients with infiltrating breast cancer
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AXILLARY LYMPH NODE;
BREAST CANCER;
CANCER ADJUVANT THERAPY;
CANCER CHEMOTHERAPY;
CANCER SURGERY;
CANCER SURVIVAL;
CLINICAL TRIAL;
COST BENEFIT ANALYSIS;
EDITORIAL;
HUMAN;
LYMPH NODE BIOPSY;
LYMPH NODE METASTASIS;
LYMPHADENECTOMY;
PRIORITY JOURNAL;
AXILLA;
BREAST NEOPLASMS;
CARCINOMA, DUCTAL, BREAST;
COST-BENEFIT ANALYSIS;
FEMALE;
HUMANS;
LYMPH NODE EXCISION;
LYMPHATIC METASTASIS;
NEOPLASM INVASIVENESS;
RANDOMIZED CONTROLLED TRIALS;
SURVIVORS;
|
|
EID: 0030823708
PISSN: 00224790
EISSN: None
Source Type: Journal
DOI: 10.1002/(SICI)1096-9098(199709)66:1<7::AID-JSO3>3.0.CO;2-8 Document Type: Editorial |
|
Times cited : (49)
|
|
References (34)
|
